Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Adeoye Y Olukotun

Director at Arrowhead Pharmaceuticals, Inc. (ARWR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $851K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC ARWRArrowhead Pharmaceuticals, Inc. Sell 2,00031,600 held (−6%) $86.96 $174K -35.7%
Dec 23SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 3,09040,510 held (−7%) $66.70 $206K -16.2%
Dec 23SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 6,08334,427 held (−15%) $68.04 $414K -17.8%
Dec 23SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 82733,600 held (−2%) $68.48 $57K -18.4%
  • Sell

    Director Adeoye Y Olukotun sold $206K of ARWR at $66.70 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Adeoye Y Olukotun sold $414K of ARWR at $68.04 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Adeoye Y Olukotun sold $57K of ARWR at $68.48 — pre-scheduled 10b5-1 plan sale.